Stock Analiz

Nutex Health Inc. (NUTX) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Net income in fiscal 2025 was $71M, a net margin of 8.1%; the best year in this period was 2021 with $133M.

Over the twelve months to September 30, 2026, revenue was $797M and net income $165M.

Free cash flow was $246M in fiscal 2025 and positive in 5 of the 10 years shown.

The diluted share count rose 1337% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $0162018: $1M182019: $1M192020: $274M202021: $332M212022: $219M222023: $248M232024: $480M242025: $875M25$875M
Net income
2016: -$7M162017: $582062172018: -$950129182019: -$7M192020: $106M202021: $133M212022: -$425M222023: -$46M232024: $52M242025: $71M25$71M
Free cash flow
2018: -$48004920182019: -$4M20192020: $25M20202021: $137M20212022: $36M20222023: -$8M20232024: $21M20242025: $246M2025$246M
EPS (diluted)
2016: $-16.04162017: $0.84172018: $-0.56182019: $-1.96192020: $0.18202021: $0.22212022: $-100.36222023: $-10.39232024: $9.69242025: $10.4825$10.48

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$797M$875M$480M$248M$219M$332M$274M$1M$1M—$0
Gross profit$381M$444M$196M$35M$15M$179M$158M$535976$859356-$7315$0
Operating income$311M$276M$131M-$32M-$407M$170M$153M-$7M-$840398-$6M-$448595
Net income$165M$71M$52M-$46M-$425M$133M$106M-$7M-$950129$582062-$7M
EPS (diluted)$23.22$10.48$9.69$-10.39$-100.36$0.22$0.18$-1.96$-0.56$0.84$-16.04
R&D—————$285880$557257$768103$545223——
Revenue growth—+82.4%+93.8%+12.9%−33.9%+21.0%+19954.5%−0.0%——−100.0%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$258M$248M$23M$1M$51M$173M$87M-$4M-$480049-$714623-$274223
Capital spending-$10M-$3M-$2M-$9M-$15M-$37M-$61M-$84002$0——
Free cash flow$248M$246M$21M-$8M$36M$137M$25M-$4M-$480049——
Dividends paid$86M$0$0$0$0$0$0$0$0$0$0
Buybacks$56M$5M$0$0———————
Stock-based pay—$108M-$129743—$189581$4M$3M$450054$155886$924326$1500

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$186M$41M$22M$34M$36M$26931$1M$119267$9449$10522
Debt—$76M$74M$59M$59M$89M$462890$640957$779779$52500—
Equity—$329M$132M$61M$96M$115M-$1M$2M-$1M-$997224-$6M
Total assets—$919M$655M$398M$432M$395M$169857$7M$449428$3M$510835
Shares (diluted)7M7M5M4M4M593M5M4M2M1M0M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin47.8%50.8%40.9%14.0%7.0%54.1%57.5%39.2%62.9%——
Operating margin39.0%31.5%27.2%-12.8%-185.4%51.4%55.9%-504.8%-61.5%——
Net margin20.7%8.1%10.8%-18.5%-193.7%40.0%38.7%-520.8%-69.5%——
FCF margin31.1%28.1%4.3%-3.3%16.4%41.2%9.3%-301.9%-35.1%——
ROIC—50.1%54.6%-23.5%-206.8%83.1%—-276.0%———
ROE—21.5%39.3%-74.5%-443.1%115.7%-9346.5%-382.9%63.4%-58.4%126.6%

Frequently asked questions

What is Nutex Health’s annual revenue?

$875M in fiscal 2025 and $797M over the twelve months to September 30, 2026.

How much profit does Nutex Health make?

Net income was $71M in fiscal 2025 (net margin 8.1%).

Is Nutex Health’s revenue growing?

Yes: revenue rose 82.4% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.